• DMOG pretreatment restores osteogenic–adipogenic balance in ONFH-derived BMSCs by promoting osteogenesis and suppressing adipogenesis.
• DMOG improves mitochondrial function, reduces oxidative stress, and enhances bioenergetic metabolism in a HIF-1α-dependent manner.
• Homer3 is identified as a downstream negative regulator of HIF-1α, aberrantly upregulated in fhBMSCs but suppressed by DMOG.
• Knockdown of Homer3 mimics DMOG effects, suggesting a potential therapeutic target for ONFH.